0.280 0 (0%) 01-05 17:35 |
|
Open: | 0.280 |
High: | 0.280 |
Low: | 0.276 |
Pre. close: | 0.280 |
Volume: | 15,168 |
Avg. volume: | 0 |
MA (50): | 0.280 |
MA (200): | 0.389 |
Year high: | 0.819 |
Year low: | 0.225 |
Market cap: | 5(M) |
EPS: | -0.44 |
PE ratio: | -0.635 |
SELL | BUY |
HeikinAshi: | |
Kaufmans AMA: | |
Chandelier (20): | |
MA (5): | |
MA (50): | |
MACD (26,12,9): | |
Slow KDJ (14,3): | |
RSI (14): | |
CCI (20): |
Mon, 06 Oct 2025
Advanced Viral Delivery Systems Revolutionizing Gene Therapy for Neurological Disorders - GlobeNewswire
Fri, 13 Sep 2024
Sana CFO Hardy to depart - BioCentury
Thu, 08 Feb 2024
Discontinued GM1 Gangliosidosis Gene Therapy Shows no Evidence of Clinical Benefit - CGTLive®
Thu, 28 Apr 2022
Screen4Care - Shortening the path to rare disease diagnosis by using newborn genetic screening and digital technologies - Università degli studi di Ferrara
Tue, 24 Apr 2018
Lysogene Signs Partnership Agreement with Dr. Hervé Moine, Researcher at the IGBMC(1) and the SATT(2) Conectus Alsace, in the Fragile X Syndrome - MarketScreener
Sun, 19 Oct 2025
©NovaStocks.com | euro Stocks quote, company news, stock charts, technical analysis. Data and information is provided for informational purposes only, is not intended for trading purposes and is not investment advice. Neither NovaStocks.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Market data provided by: Financial Modeling Prep
Privacy Policy: Third parties, including Google, may be placing and reading cookies on your browsers, or other methods to collect information as a result of ad serving on this website. Third parties' use of advertising cookies enables it and its partners to serve ads to you based on your visit to this site and/or other sites on the Internet. You may opt out of personalized advertising by visiting Ads Settings. If you choose to use this website, you agree to the collection and use of information in relation to this policy. The information collected is used for providing and improving the ads Service. We will not use or share information with anyone, and we do not store any data from users.